Ledger.Open graph →
SEC Form D · filed August 22, 2019

ONL Therapeutics, Inc

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ANN ARBOR, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Xueying Wang · Austin, TXDirectorJustin M. Quigley · Vancouver, British Columbia, CanadaDirectorBenjamin Tsai · Los Angeles, CAExec · DirectorOmead K. Ostadan · Redwood City, CAExec · DirectorPatricio Varas · Vancouver, British Columbia, CanadaDirectorJoseph Lemnah · Williston, VTExec · DirectorGunther Van Dender · St. George, UTDirectorAnn P. Hailer · New York, NYDirectorCatherine Badalamente · Detroit, MIDirectorThomas E. Preston · Jamestown, KYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗